Dupont Capital Management’s European Biotech Acquisition Corp. Class A Ordinary Shares EBAC Stock Holding History

Dupont Capital Management’s Portfolio EBAC Stock Details EBAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-99,996	Closed	-$1.01M	–	1387
2022 Q4	$1.01M	Hold	99,996	–	–	0.05%	341
2022 Q3	$992K	Hold	99,996	–	–	0.06%	385
2022 Q2	$978K	Hold	99,996	–	–	0.05%	482
2022 Q1	$976K	Hold	99,996	–	–	0.04%	525
2021 Q4	$970K	Hold	99,996	–	–	0.03%	568
2021 Q3	$971K	Hold	99,996	–	–	0.03%	607
2021 Q2	$966K	Buy	+99,996	New	+$982K	0.02%	651

Dupont Capital Management's EBAC Position: Q1 2023 in Review

Dupont Capital Management sold out of European Biotech Acquisition Corp. Class A Ordinary Shares (EBAC) in Q1 2023, closing a stake of 99,996 shares — an estimated $1.01M sold.

Dupont Capital Management first reported a position in EBAC in Q2 2021 and held it in 7 quarters. The position peaked at $1.01M in Q4 2022. 0 funds tracked by Wall St. Rank hold EBAC as of Q1 2023.

Dupont Capital Management reported no remaining European Biotech Acquisition Corp. Class A Ordinary Shares position as of Q1 2023 after selling out during the quarter.
Dupont Capital Management sold 99,996 European Biotech Acquisition Corp. Class A Ordinary Shares shares in Q1 2023, an estimated $1.01M.
Dupont Capital Management first reported a position in European Biotech Acquisition Corp. Class A Ordinary Shares in Q2 2021 and held it in 7 quarters.
Dupont Capital Management's European Biotech Acquisition Corp. Class A Ordinary Shares position peaked at $1.01M in Q4 2022.
0 funds tracked by Wall St. Rank held European Biotech Acquisition Corp. Class A Ordinary Shares as of Q1 2023.

Based on Dupont Capital Management's 13F filing for Q1 2023, filed 28 Apr 2023.